Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24508383
Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24518289
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against LPS-Induced Impairments in Rat Caudate Nucleus. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24510751
Sterol Carrier Protein-2: Binding Protein for Endocannabinoids. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24510313
Targeting the cannabinoid system for pain relief? (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24529672
Changes in Cerebral CB1 Receptor Availability after Acute and Chronic Alcohol Abuse and Monitored Abstinence. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24553924
Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24561047
Cannabinoid receptor type 1 activation by arachidonylcyclopropylamide in rat aortic rings causes vasorelaxation involving calcium-activated potassium channel subunit alpha-1 and calcium channel, voltage-dependent, L type, alpha 1C subunit. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24561046
Strain differences in the expression of endocannabinoid genes and in cannabinoid receptor binding in the brain of Lewis and Fischer 344 rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24607771
Optimization of Chemical Functionalities of Indole-2-Carboxamides to Improve Allosteric Parameters for the Cannabinoid Receptor 1 (CB1). (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24635495
Endocannabinoid-Hydrolysing Enzymes in the Post-Mortem Cerebellum of Humans Affected by Hereditary Autosomal Dominant Ataxias. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24642775
Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/23808969
Elevation of Endogenous Anandamide Impairs LTP, Learning and Memory through CB1 Receptor Signaling in Mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24648181
Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASB. (abst – 2014) http://onlinelibrary.wiley.com/doi/1...12716/abstract
Upregulation of Cannabinoid Receptor-1 and Fibrotic Activation of Mouse Hepatic Stellate Cells during Schistosoma J. Infection: Role of NADPH Oxidase. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24657416
Anticonvulsant Effects of N-Arachidonoyl-Serotonin, a Dual FAAH Enzyme and TRPV1 Channel Blocker, on Experimental Seizures: The Roles of Cannabinoid CB1 Receptors and TRPV1 Channels. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24674273
Low anandamide doses facilitate male rat sexual behaviour through the activation of CB1 receptors. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24671517
Involvement of cannabinoid receptor-1 activation in mitochondrial depolarizing effect of lipopolysaccharide in human spermatozoa. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24692267
Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24698342
Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24703998
Mutation of Putative GRK Phosphorylation Sites in the Cannabinoid Receptor 1 (CB1R) Confers Resistance to Cannabinoid Tolerance and Hypersensitivity to Cannabinoids in Mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24719095
The CB1 Receptor as an Important Mediator of Hedonic Reward Processing. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24718372
Cannabinoid receptor type 1 immunoreactivity and disease severity in human epithelial ovarian tumors. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24721263
The cannabinoid acids, analogs and endogenous counterparts. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24731541
Modulation of the extinction of fear learning. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24742526
Anandamide attenuates haloperidol-induced vacuous chewing movements in rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24747871
Endocannabinoid-mediated retrograde modulation of synaptic transmission. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24747340
Inhibition of Peripheral Fatty Acid Amide Hydrolase Depresses Activities of Bladder Mechanosensitive Nerve Fibers of the Rat. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24746881
Cannabinoid 1 receptors in keratinocytes attenuate FITC-induced mouse atopic-like dermatitis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24750433
Effect of N-Arachidonoyl Dopamine on Activity of Neuronal Network in Primary Hippocampus Culture upon Hypoxia Modelling. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24771427
Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24813296
Cannabinoid Type 1 Receptor Availability in the Amygdala Mediates Threat Processing in Trauma Survivors. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24820537
Ultramicronized palmitoylethanolamide normalizes intestinal motility in a murine model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24818658
Harnessing neuroendocrine controls of keratin expression: A new therapeutic strategy for skin diseases? (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24823963
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24836296
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24373545
O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24853577
Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24858366
In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: inhalation versus intraperitoneal injection. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24857780
Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute d-amphetamine. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24867330
WIN55212-2 impairs non-associative, recognition and spatial memory in rats via CB1 receptor stimulation. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24867078
Cannabinoids Prevent the Effects of a Footshock Followed by Situational Reminders on Emotional Processing. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24897957
Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24906199
Morphological and Behavioural Evidence for Impaired Prefrontal Cortical Function in Female CB1 Receptor Deficient Mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24907533
Stress regulates endocannabinoid-CB1 receptor signaling. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24882055
The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24911644
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24911431
Functions of the CB1 and CB 2 Receptors in Neuroprotection at the Level of the Blood-Brain Barrier. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24929655
The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24927567
The endocannabinoid system and appetite: relevance for food reward. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24933167
β-Amyloid Inhibits E-S Potentiation through Suppression of Cannabinoid Receptor 1- Dependent Synaptic Disinhibition. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24945775
Cyclic ovarian hormone modulation of supraspinal Δ9-tetrahydrocannabinol-induced antinociception and cannabinoid receptor binding in the female rat. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24951841
Type-1 Cannabinoid Receptor Activity During Alzheimer's Disease Progression. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24946872
CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24967683
Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24972960
Role of CNR1 polymorphisms in moderating the effects of psychosocial adversity on impulsivity in adolescents. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24980155
Acute Resistance Exercise Induces Antinociception by Activation of the Endocannabinoid System in Rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24977916
Ligand Activation of Cannabinoid Receptors Attenuates Hypertrophy of Neonatal Rat Cardiomyocytes. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24979612
Inhibition of diacylglycerol lipase (DAGL) in the lateral hypothalamus of rats prevents the increase in REMS and food ingestion induced by PAR1 stimulation. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24996194
Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25002257
Haloperidol and rimonabant increase delay discounting in rats fed high-fat and standard chow diets. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25000488
Endocannabinoid signaling modulates neurons of the pedunculopontine nucleus (PPN) via astrocytes. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25009314
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against Homocysteine-Induced Impairments in Rat Caudate Nucleus Through CB1 Receptor. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25007951
CB1 receptor antagonism in the granular insular cortex or somatosensory area facilitates consolidation of object recognition memory. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25004406
Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25014618
Reductions in Endocannabinoid Levels and Enhanced Coupling of Cannabinoid Receptors in the Striatum are Accompanied by Cognitive Impairments in the AβPPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease (abst – 2014) http://iospress.metapress.com/conten...51455c445&pi=4
The Potential Therapeutic Effects of THC on Alzheimer's Disease (abst – 2014) http://iospress.metapress.com/conten...d253bd883&pi=8
Allosteric Modulation of a Cannabinoid G Protein-coupled Receptor BINDING SITE ELUCIDATION AND RELATIONSHIP TO G PROTEIN SIGNALING (abst – 2014) http://www.jbc.org/content/289/9/582...c-2f6edbe16774
The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects (abst – 2014) http://onlinelibrary.wiley.com/doi/1...12160/abstract
Cannabinoid receptor intracellular signalling: The long journey from binding sites to biological effects (abst – 2014) http://onlinelibrary.wiley.com/doi/1...81.ch2/summary
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage (abst – 2014) http://onlinelibrary.wiley.com/doi/1...23452/abstract
The therapeutic efficacy of cannabinoid receptor type 1 ligands in Huntington's disease may depend on their functional selectivity (abst – 2014) http://www.fasebj.org/content/28/1_S...7-3f56f520a102
Endocannabinoid modulation by FAAH and MAGL within the analgesic circuitry of the periaqueductal grey. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25041240
Dual agonism of peripheral cannabinoid CB1/CB2 receptors suppresses cardiac myocyte hypertrophy (abst – 2014) http://www.fasebj.org/content/28/1_S...6-4103f0c84daf
Fatty Acid-binding Protein 5 (FABP5) Regulates Cognitive Function Both by Decreasing Anandamide Levels and by Activating the Nuclear Receptor Peroxisome Proliferator activated Receptor β/δ (PPARβ/δ) in the Brain (abst – 2014) http://www.jbc.org/content/289/18/12...3-49611e578de4
Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24075694
The analgesic effect of dipyrone in peripheral tissue involves two different mechanisms: Neuronal KATP channel opening and CB1 receptor activation. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25058903
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25058512
The interaction between serotonergic and cannabinoidergic modulations involved in the fear extinction (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25069241
Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24642775
Activation of CB1 inhibits NGF-induced sensitization of TRPV1 in adult mouse afferent neurons. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25088915
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24644287
Effects of cannabinoids on tension induced by acetylcholine and choline in slow skeletal muscle fibers of the frog. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24218022
Hormone shows promise at negating marijuana's high effect (news – 2014) http://www.cbsnews.com/news/hormone-...s-high-effect/
Muting Marijuana’s High: Pot Without the Impairment (news – 2014) http://healthland.time.com/2014/01/0...he-impairment/
Mechanism elucidated: How smell perception influences food intake (news – 2014) http://www.sciencedaily.com/releases...0210114550.htm
Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24518289
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against LPS-Induced Impairments in Rat Caudate Nucleus. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24510751
Sterol Carrier Protein-2: Binding Protein for Endocannabinoids. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24510313
Targeting the cannabinoid system for pain relief? (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24529672
Changes in Cerebral CB1 Receptor Availability after Acute and Chronic Alcohol Abuse and Monitored Abstinence. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24553924
Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24561047
Cannabinoid receptor type 1 activation by arachidonylcyclopropylamide in rat aortic rings causes vasorelaxation involving calcium-activated potassium channel subunit alpha-1 and calcium channel, voltage-dependent, L type, alpha 1C subunit. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24561046
Strain differences in the expression of endocannabinoid genes and in cannabinoid receptor binding in the brain of Lewis and Fischer 344 rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24607771
Optimization of Chemical Functionalities of Indole-2-Carboxamides to Improve Allosteric Parameters for the Cannabinoid Receptor 1 (CB1). (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24635495
Endocannabinoid-Hydrolysing Enzymes in the Post-Mortem Cerebellum of Humans Affected by Hereditary Autosomal Dominant Ataxias. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24642775
Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/23808969
Elevation of Endogenous Anandamide Impairs LTP, Learning and Memory through CB1 Receptor Signaling in Mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24648181
Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASB. (abst – 2014) http://onlinelibrary.wiley.com/doi/1...12716/abstract
Upregulation of Cannabinoid Receptor-1 and Fibrotic Activation of Mouse Hepatic Stellate Cells during Schistosoma J. Infection: Role of NADPH Oxidase. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24657416
Anticonvulsant Effects of N-Arachidonoyl-Serotonin, a Dual FAAH Enzyme and TRPV1 Channel Blocker, on Experimental Seizures: The Roles of Cannabinoid CB1 Receptors and TRPV1 Channels. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24674273
Low anandamide doses facilitate male rat sexual behaviour through the activation of CB1 receptors. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24671517
Involvement of cannabinoid receptor-1 activation in mitochondrial depolarizing effect of lipopolysaccharide in human spermatozoa. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24692267
Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24698342
Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24703998
Mutation of Putative GRK Phosphorylation Sites in the Cannabinoid Receptor 1 (CB1R) Confers Resistance to Cannabinoid Tolerance and Hypersensitivity to Cannabinoids in Mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24719095
The CB1 Receptor as an Important Mediator of Hedonic Reward Processing. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24718372
Cannabinoid receptor type 1 immunoreactivity and disease severity in human epithelial ovarian tumors. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24721263
The cannabinoid acids, analogs and endogenous counterparts. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24731541
Modulation of the extinction of fear learning. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24742526
Anandamide attenuates haloperidol-induced vacuous chewing movements in rats (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24747871
Endocannabinoid-mediated retrograde modulation of synaptic transmission. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24747340
Inhibition of Peripheral Fatty Acid Amide Hydrolase Depresses Activities of Bladder Mechanosensitive Nerve Fibers of the Rat. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24746881
Cannabinoid 1 receptors in keratinocytes attenuate FITC-induced mouse atopic-like dermatitis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24750433
Effect of N-Arachidonoyl Dopamine on Activity of Neuronal Network in Primary Hippocampus Culture upon Hypoxia Modelling. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24771427
Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24813296
Cannabinoid Type 1 Receptor Availability in the Amygdala Mediates Threat Processing in Trauma Survivors. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24820537
Ultramicronized palmitoylethanolamide normalizes intestinal motility in a murine model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24818658
Harnessing neuroendocrine controls of keratin expression: A new therapeutic strategy for skin diseases? (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24823963
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24836296
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24373545
O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24853577
Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24858366
In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: inhalation versus intraperitoneal injection. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24857780
Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute d-amphetamine. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24867330
WIN55212-2 impairs non-associative, recognition and spatial memory in rats via CB1 receptor stimulation. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24867078
Cannabinoids Prevent the Effects of a Footshock Followed by Situational Reminders on Emotional Processing. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24897957
Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24906199
Morphological and Behavioural Evidence for Impaired Prefrontal Cortical Function in Female CB1 Receptor Deficient Mice. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24907533
Stress regulates endocannabinoid-CB1 receptor signaling. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24882055
The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24911644
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24911431
Functions of the CB1 and CB 2 Receptors in Neuroprotection at the Level of the Blood-Brain Barrier. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24929655
The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24927567
The endocannabinoid system and appetite: relevance for food reward. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24933167
β-Amyloid Inhibits E-S Potentiation through Suppression of Cannabinoid Receptor 1- Dependent Synaptic Disinhibition. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24945775
Cyclic ovarian hormone modulation of supraspinal Δ9-tetrahydrocannabinol-induced antinociception and cannabinoid receptor binding in the female rat. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24951841
Type-1 Cannabinoid Receptor Activity During Alzheimer's Disease Progression. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24946872
CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24967683
Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24972960
Role of CNR1 polymorphisms in moderating the effects of psychosocial adversity on impulsivity in adolescents. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24980155
Acute Resistance Exercise Induces Antinociception by Activation of the Endocannabinoid System in Rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24977916
Ligand Activation of Cannabinoid Receptors Attenuates Hypertrophy of Neonatal Rat Cardiomyocytes. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24979612
Inhibition of diacylglycerol lipase (DAGL) in the lateral hypothalamus of rats prevents the increase in REMS and food ingestion induced by PAR1 stimulation. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24996194
Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25002257
Haloperidol and rimonabant increase delay discounting in rats fed high-fat and standard chow diets. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25000488
Endocannabinoid signaling modulates neurons of the pedunculopontine nucleus (PPN) via astrocytes. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25009314
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against Homocysteine-Induced Impairments in Rat Caudate Nucleus Through CB1 Receptor. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25007951
CB1 receptor antagonism in the granular insular cortex or somatosensory area facilitates consolidation of object recognition memory. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25004406
Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25014618
Reductions in Endocannabinoid Levels and Enhanced Coupling of Cannabinoid Receptors in the Striatum are Accompanied by Cognitive Impairments in the AβPPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease (abst – 2014) http://iospress.metapress.com/conten...51455c445&pi=4
The Potential Therapeutic Effects of THC on Alzheimer's Disease (abst – 2014) http://iospress.metapress.com/conten...d253bd883&pi=8
Allosteric Modulation of a Cannabinoid G Protein-coupled Receptor BINDING SITE ELUCIDATION AND RELATIONSHIP TO G PROTEIN SIGNALING (abst – 2014) http://www.jbc.org/content/289/9/582...c-2f6edbe16774
The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects (abst – 2014) http://onlinelibrary.wiley.com/doi/1...12160/abstract
Cannabinoid receptor intracellular signalling: The long journey from binding sites to biological effects (abst – 2014) http://onlinelibrary.wiley.com/doi/1...81.ch2/summary
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage (abst – 2014) http://onlinelibrary.wiley.com/doi/1...23452/abstract
The therapeutic efficacy of cannabinoid receptor type 1 ligands in Huntington's disease may depend on their functional selectivity (abst – 2014) http://www.fasebj.org/content/28/1_S...7-3f56f520a102
Endocannabinoid modulation by FAAH and MAGL within the analgesic circuitry of the periaqueductal grey. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25041240
Dual agonism of peripheral cannabinoid CB1/CB2 receptors suppresses cardiac myocyte hypertrophy (abst – 2014) http://www.fasebj.org/content/28/1_S...6-4103f0c84daf
Fatty Acid-binding Protein 5 (FABP5) Regulates Cognitive Function Both by Decreasing Anandamide Levels and by Activating the Nuclear Receptor Peroxisome Proliferator activated Receptor β/δ (PPARβ/δ) in the Brain (abst – 2014) http://www.jbc.org/content/289/18/12...3-49611e578de4
Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24075694
The analgesic effect of dipyrone in peripheral tissue involves two different mechanisms: Neuronal KATP channel opening and CB1 receptor activation. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25058903
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25058512
The interaction between serotonergic and cannabinoidergic modulations involved in the fear extinction (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25069241
Endocannabinoid-hydrolysing enzymes in the post-mortem cerebellum of humans affected by hereditary autosomal dominant ataxias. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24642775
Activation of CB1 inhibits NGF-induced sensitization of TRPV1 in adult mouse afferent neurons. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25088915
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24644287
Effects of cannabinoids on tension induced by acetylcholine and choline in slow skeletal muscle fibers of the frog. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24218022
Hormone shows promise at negating marijuana's high effect (news – 2014) http://www.cbsnews.com/news/hormone-...s-high-effect/
Muting Marijuana’s High: Pot Without the Impairment (news – 2014) http://healthland.time.com/2014/01/0...he-impairment/
Mechanism elucidated: How smell perception influences food intake (news – 2014) http://www.sciencedaily.com/releases...0210114550.htm